Frailty modeling of age-incidence curves of osteosarcoma and Ewing sarcoma among individuals younger than 40years

Statistics in Medicine

Volumn 31, Issue 28, 2012, Pages 3731-3747

  Valberg, Morten ^a   Grotmol, Tom ^b   Tretli, Steinar ^b   Veierød, Marit B ^a   Devesa, Susan S ^c   Aalen, Odd O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Ewing sarcoma; Frailty; Growth spurt; Osteosarcoma; Survival analysis; Susceptibility

Indexed keywords

ARMITAGE DOLL MODEL; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MODEL; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; EWING SARCOMA; GROWTH ACCELERATION; GROWTH CURVE; HUMAN; MATHEMATICAL MODEL; OSTEOSARCOMA; POISSON DISTRIBUTION; SURVIVAL RATE;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ADULT; AGE DISTRIBUTION; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MODELS, BIOLOGICAL; OSTEOSARCOMA; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODELS; RARE DISEASES; SARCOMA, EWING; YOUNG ADULT;

EID: 84870236846     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5441     Document Type: Article

References (34)

1. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. British Journal of Cancer 1954; 8:1-12. DOI: 10.1038/bjc.1954.1.
2. Aalen OO, Tretli S. Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes and Control 1999; 10:285-292. DOI: 10.1023/A:1008916718152.
3. Svensson E, Moger TA, Tretli S, Aalen OO, Grotmol T. Frailty modelling of colorectal cancer incidence in Norway: indications that individual heterogeneity in risk is related to birth cohort. European Journal of Epidemiology 2006; 21:587-593. DOI: 10.1007/s10654-006-9043-8.
4. Haugen M, Bray F, Grotmol T, Tretli S, Aalen OO, Moger TA. Frailty modeling of bimodal age-incidence curves of nasopharyngeal carcinoma in low-risk populations. Biostatistics 2009; 10:501-514. DOI: 10.1093/biostatistics/kxp007.
5. Grotmol T, Bray F, Holte H, Haugen M, Kunz L, Tretli S, Aalen OO, Moger TA. Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countries. Cancer Epidemiology, Biomarkers & Prevention 2011; 20:1350-1357. DOI: 10.1158/1055-9965.EPI-10-1014.
6. Il'yasova D, Siamakpour-Reihani S, Akushevich I, Akushevich L, Spector N, Schildkraut J. What can we learn from the age- and race/ethnicity-specific rates of inflammatory breast carcinoma?. Breast Cancer Research and Treatment 2011; 130:691-697. DOI: 10.1007/s10549-011-1719-4.
7. Kravchenko J, Akushevich I, Seewaldt VL, Abernethy AP, Lyerly HK. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms. Breast Cancer Research and Treatment 2011; 128:483-493. DOI: 10.1007/s10549-011-1347-z.
8. Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogolowkin M. Malignant bone tumors. In Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29Years of Age, Including SEER Incidence and Survival: 1975-2000, Bleyer A, O'Leary M, Barr R, Ries LAG (eds), NIH Pub. No. 06-5767, National Cancer Institute: Bethesda, MD, 2006; 97-110.
9. Miller RW, Boice JD, Curtis RE. Bone cancers. In Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni JF (eds). Oxford University Press: New York, 2006; 946-958.
10. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009; 115:1531-1543. DOI: 10.1002/cncr.24121.
11. Eyre R, Feltbower RG, Mubwandarikwa E, Eden TO, McNally RJ. Epidemiology of bone tumours in children and young adults. Pediatric Blood & Cancer 2009; 53:941-952. DOI: 10.1002/pbc.22194.
12. Savage SA, Mirabello L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma 2011; 2011:548151. DOI: 10.1155/2011/548151.
13. Mirabello L, Pfeiffer R, Murphy G, Daw NC, Patino-Garcia A, Troisi RJ, Hoover RN, Douglass C, Schuz J, Craft AW, Savage SA. Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes and Control 2011; 22:899-908. DOI: 10.1007/s10552-011-9763-2.
14. Mirabello L, Berndt SI, Seratti GF, Burdett L, Yeager M, Chowdhury S, Teshome K, Uzoka A, Douglass C, Hayes RB, Hoover RN, Savage SA, Simon MA, Gebhardt MC, Scarborough MT, Gitelis S, Eckardt JJ, Neff JR, Joyce MJ, Malawer M, McGuire M, Anderson HC. Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis 2010; 31:1400-1404. DOI: 10.1093/carcin/bgq117.
15. Mirabello L, Richards EG, Duong LM, Yu K, Wang Z, Cawthon R, Berndt SI, Burdett L, Chowdhury S, Teshome K, Douglass C, Savage SA. Telomere length and variation in telomere biology genes in individuals with osteosarcoma. International Journal of Molecular Epidemiology and Genetics 2011; 2(1):19-29.
16. Mirabello L, Yu K, Berndt SI, Burdett L, Wang Z, Chowdhury S, Teshome K, Uzoka A, Hutchinson A, Grotmol T, Douglass C, Hayes RB, Hoover RN, Savage SA, Study Group TN. A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer 2011; 11:209. DOI: 10.1186/1471-2407-11-209.
17. Toomey EC, Schiffman JD, Lessnick SL. Recent advances in the molecular pathogenesis of Ewing's sarcoma. Oncogene 2010; 29:4504-4516. DOI: 10.1038/onc.2010.205.
18. Aalen OO, Borgan Ø, Gjessing HK. Survival and Event History Analysis: A Process Point of View. Springer: New York, 2008. DOI: 10.1007/978-0-387-68560-1.
19. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER Stat Database: Incidence-SEER 9 Regs Research Data, Nov 2007 Sub (1973-2005)- Linked To County Attributes - Total U.S., 1969-2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission, 2008.
20. Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, Grotmol T. Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976-2005). Cancer Epidemiology, Biomarkers & Prevention 2011; 20:1770-1777. DOI: 10.1158/1055-9965.EPI-11-0136.
21. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America 1971; 68:820-823. DOI: 10.1073/pnas.68.4.820.
22. Hougaard P. Analysis of Multivariate Survival Data. Springer-Verlag: New York, 2000.
23. Duchateau L, Janssen P. The Frailty Model. Springer: New York, 2008. DOI: 10.1007/978-0-387-72835-3.
24. Wienke A. Frailty Models in Survival Analysis. Chapman & Hall/CRC: Boca Raton, 2011. DOI: 10.1201/9781420073911-f.
25. Manton KG, Akushevich I, Kulminski A. Human mortality at extreme ages: data from the NLTCS and Linked Medicare Records. Mathematical Population Studies: An International Journal of Mathematical Demography 2008; 15:137-159. DOI: 10.1080/08898480802221665.
26. Maller R, Zhou X. Survival Analysis with Long-Term Survivors. Wiley: New York, 1996.
27. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. European Journal of Cancer 2009; 45:747-755. DOI: 10.1016/j.ejca.2008.11.032.
28. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. European Journal of Cancer 2009; 45:756-764. DOI: 10.1016/j.ejca.2008.11.033.
29. Abbassi V. Growth and normal puberty. Pediatrics 1998; 102:507-511.
30. Moger TA, Aalen OO, Halvorsen TO, Storm HH, Tretli S. Frailty modelling of testicular cancer incidence using Scandinavian data. Biostatistics 2004; 5:1-14, DOI: 10.1093/biostatistics/5.1.1.
31. Aalen OO. Phase type distributions in survival analysis. Scandinavian Journal of Statistics 1995; 22:447-463.
32. Melnick S, Cole P, Anderson D, Herbst A. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. New England Journal of Medicine 1987; 316:514-516. DOI: 10.1056/NEJM198702263160905.
33. Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. Journal of Clinical Oncology 2011; 29(3):257-263. DOI: 10.1200/JCO.2010.28.7078.
34. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. Journal of the National Cancer Institute 1993; 85(1):25-31. DOI: 10.1093/jnci/85.1.25.